| Tag | Content |
|---|
EnhancerAtlas ID | HS104-04140 |
Organism | Homo sapiens |
Tissue/cell | HUVEC |
Coordinate | chr1:161581530-161583380 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | GTTTTCATAG ACCAGACTCC AGCCTACAAT ACAGGAAAAA TAGATTTAGT TCTATATGTG 60
CAGAGAAGCA CAAATAATTT TCGTAAATGT AGATACCCAG GATAAAACGC AGTGTTGACC 120
GATCGAAAAG TCTTTCTCTA AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG 180
AAAAGTAAGG ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG 240
GAGGGTGCGA TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC 300
TAAACTTCCT AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA 360
TTAATGTGTC TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA 420
GCGGGAAAAA TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA 480
CCTTAAGGCT CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT 540
CGAGCCATGT CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC 600
ACTGTTGCTG AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT 660
GGGAGCTACG GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC 720
GGCGGTGCTC AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC 780
AGAGCAAGTG GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA 840
AGAATCGGTT CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG 900
ACACTGCTAG AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA 960
AATTCCAAAC CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT 1020
TAACGCGGGT TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT 1080
TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC 1140
AATACCTCAC TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC 1200
TTTTTTTGAA GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC 1260
CAACTCTTGA GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG 1320
GGGCTCTTGT GTCTTCACTT GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG 1380
CCCCTAATTA TTCCCGGCCG AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG 1440
TCCCAGGCCA AGGTCCCAGG CCAACCTAAA TCACGCATTC TCCAAAACAG CCGGCAAACT 1500
AAGCACATTC CTTCCCGTTT CCAGTCCATA AACCCCCCCC CCCAAGTGGC CTCATAGTAA 1560
GCAACTCATT CGGGCCCCCT CTCTGCTGGC AAAAAGCTCA GATGTACTGG ACTGTGCATT 1620
TGATTTGGAA CTGAGTTACA TGGGAGAGAA GCAGGGATTC AGTTTGGCTG GGAATCAAAC 1680
TCTTTTGATA ATTTCCTAAT AAACTGATAG TCATTAGATG ACTTGTAGTC TCGATAAGTT 1740
GAAACTTTTT CCTAACATGC TGTTTATGAT ACTGAGTTCT TTGTCACCGG TTGAACTAAC 1800
AGCAATTGTA TTCACAAATT TTCCAGCCTT TAAAATACTG TCTGAGGGTT 1850
|
